Navigation Links
China Osteoporosis Drug Market 2013 Analysis & 2017 Forecasts in New Research Report at ChinaMarketResearchReports.com
Date:11/11/2013

Dallas, TX (PRWEB) November 12, 2013

Osteoporosis is a systemic bone disease, a common disease among middle and old-aged people. It is characterized by low bone mineral density and deterioration of bone microarchitecture, which can lead to increased risks of fragility fracture. There are over 200 million osteoporosis patients around the world in the current stage. Regarding the genders of osteoporosis patients, the number of female patients is much larger than that of male patients, and the former are attacked by osteoporosis much earlier than the latter.

According to the data of Ministry of Civil Affairs of China, by the end of 2012, the population that were 60 years old and above was 193.9 million, taking up 14.3% of the total population; the population that were 65 years old and above was 127.14 million, taking up 9.4%. China has the largest old-aged population around the world, and the incidence rate of osteoporosis keeps increasing year after year. The number of patients diagnosed with osteoporosis in China is over 70 million, and the number of female patients is triple as much as that of male patients. 40%-50% patients are 60 years old or above, and about 25% patients have suffered fractures because of osteoporosis. The incidence of fracture, pain and deformation of spinal column keeps increasing.

Complete report is available @ http://www.chinamarketresearchreports.com/114662.html .

More than 30 kinds of osteoporosis drugs have been launched into the market in the world. Clinically, bisphosphonates, parathyroid hormones, selective estrogen receptor modulators and activated vitamin D and analogues are used most often, which is the same as the situation in China. However, some newly launched osteoporosis drugs overseas are not launched in China yet, such as bazedoxifene acetate, eldecalcitol and some prolonged action preparations of bisphosphonates.

In 2012, the global market size of 6 kinds of osteoporosis drugs was each over USD 1 billion. Top 3 drugs all belong to bisphosphonates: zoledronic acid, risedronate sodium and alendronate sodium. The market size of zoledronic acid is the largest, about USD 2 billion.

During 2008-2012, bisphosphonates, activated vitamin D and analogues, and calcitonins always took up above 98% shares of China osteoporosis drug market. The market share of bisphosphonates increased at the highest speed; that of activated vitamin D and analogues remained stable; that of calcitonins significantly decreased since 2011.

During 2008-2012, regarding the osteoporosis drugs in China hospital market, the market size of osteoporosis drugs of Jiangsu Hengrui Medicine Co., Ltd. increased at the highest speed, and CAGR (compound average growth rate) was 42.4%; the growth rate of Qingdao Chiatai Haier Pharmaceutical Co., Ltd. ranked the second, and CAGR was 36.1%; CAGR of Novartis was 33%, in spite of its large base figure. Therefore, Novartis is the most excellent enterprise.

With the increasingly serious problem of aging of population, the number of osteoporosis patients increases at high speed accordingly. It is predicted that there will be over 200 million patients by 2050. For global pharmaceutical enterprises, they will find huge market opportunities in China.

Through this report, the readers can acquire the following information:

  •     Incidence status of osteoporosis
  •     Supply and demand status of osteoporosis drugs in China
  •     Market status of sub-varieties of osteoporosis drugs
  •     Competition status of China market
  •     Market opportunities of osteoporosis drugs in China

The following enterprises and people are proposed to purchase this report:

  •     Pharmaceutical enterprises
  •     Medicine trading enterprises
  •     Medical Institutions
  •     Investors/research institutes concerned about China pharmaceutical market

Purchase a copy of this report @ http://www.chinamarketresearchreports.com/contacts/purchase.php?name=114662 .

Browse more reports on Life Sciences Industry @ http://www.chinamarketresearchreports.com/cat/life-sciences.html .

About Us:
ChinaMarketResearchReports.com (http://www.chinamarketresearchreports.com/ .) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/china-osteoporosis-drug/industry-2013-2017/prweb11320746.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. China Injection Moulding Factory DuratecPlastics.com Unveils Its New Collection Of Plastic Moulds For Electronic Parts
2. Dental Care Market in China 2012-2016: Worldwide Latest Market Share, Investment Trends, Growth, Size, Strategy And Forecast Research
3. Casket Wholesale from China Casket Manufacturer MillionaireCasket.com
4. China Plastic Injection Molding Company DuratecPlastics.com: Cheap Plastic Designs For November
5. Research and Development Forecast of China’s Water Purifier Industry, 2013-2017
6. New and High Quality Men’s Clothes Online from China’s Reliable Supplier, 4leafcity.com
7. China Plastic Injection Moulding Company DuratecPlastics.com Adds 28 Items To Its Product Line
8. Report on China’s Raw Milk Powder Market Supply and Demand
9. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
10. China Plastic Injection Mould Company DuratecPlastics.com Announces Great Discounts on its Custom 3D Mould Designs
11. Globalsurance Releases New Article on Health Concerns in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
Breaking Medicine Technology: